相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis
Thomas Kristensen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis
C. Teodosio et al.
LEUKEMIA (2012)
Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis
Fabiola Traina et al.
PLOS ONE (2012)
Blood CD34-c-Kit+ cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor
Sophie Georgin-Lavialle et al.
BLOOD (2011)
Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay
Thomas Kristensen et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)
Peter Valent et al.
BLOOD (2010)
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms
James W. Vardiman
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
A critical reappraisal of treatment response criteria in systemic mastocytosis and a proposal for revisions
A. Pardanani et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis
Philipp Erben et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)
Karl Sotlar et al.
JOURNAL OF PATHOLOGY (2010)
The 2008 World Health Organization Classification System for Myeloproliferative Neoplasms Order Out of Chaos
Ayalew Tefferi et al.
CANCER (2009)
Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories
M. C. Mueller et al.
LEUKEMIA (2008)
Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR
J. A. Schumacher et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Sensitive detection of KIT D816V in patients with mastocytosis
Angela Tan et al.
CLINICAL CHEMISTRY (2006)
Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia
Christopher L. Corless et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders:: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients
Andres C. Garcia-Montero et al.
BLOOD (2006)
The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
Eric Lippert et al.
BLOOD (2006)
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT Isoforms associated with human malignancies
MM Schittenhelm et al.
CANCER RESEARCH (2006)
Clonality and molecular pathogenesis of mastocytosis
C Akin
ACTA HAEMATOLOGICA (2005)
Mastocytosis: Pathology, genetics, and current options for therapy
P Valent et al.
LEUKEMIA & LYMPHOMA (2005)
The biology of Kit in disease and the application of pharmacogenetics
C Akin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis
ML Taylor et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia
A Pardanani et al.
LEUKEMIA RESEARCH (2003)
Evolution of urticaria pigmentosa into indolent systemic mastocytosis: Abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL
F Noack et al.
LEUKEMIA & LYMPHOMA (2003)
Detection of c-kit point mutation Asp-816 → Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia
K Sotlar et al.
LEUKEMIA RESEARCH (2002)
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene
AS Yavuz et al.
BLOOD (2002)
Smouldering mastocytosis: A novel subtype of systemic mastocytosis with slow progression
P Valent et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Diagnostic criteria and classification of mastocytosis:: a consensus proposal
P Valent et al.
LEUKEMIA RESEARCH (2001)
Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings
HP Horny et al.
LEUKEMIA RESEARCH (2001)
分享论文
